AGIOS PHARMACEUTICALS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.84 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 8.84M shares, a 3.15% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 9.03M shares, a 5.65% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 8.41M shares, a 142.56% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 8.57M shares, a 8.49% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 8.17M shares, a 102.98% increase from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 4.03M shares, a 40.83% decline from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.80M shares, a 1.85% decline from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.93M shares, a 18.67% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 8.84M shares 10-Q · filed 2026-07-30 | |||||
| 2026-03-31 | 9.03M shares 10-Q · filed 2026-04-29 | |||||
| 2025-12-31 | 8.17M shares 10-K · filed 2026-02-12 | |||||
| 2025-09-30 | 8.41M shares 10-Q · filed 2025-10-30 | 8.41M shares 10-Q · filed 2025-10-30 | ||||
| 2025-06-30 | 8.57M shares 10-Q · filed 2026-07-30 | |||||
| 2025-03-31 | 8.55M shares 10-Q · filed 2026-04-29 | |||||
| 2024-12-31 | 4.03M shares 10-K · filed 2026-02-12 | |||||
| 2024-09-30 | 3.47M shares 10-Q · filed 2025-10-30 | 5.27M shares 10-Q · filed 2025-10-30 | ||||
| 2024-06-30 | 7.90M shares 10-Q · filed 2025-07-31 | |||||
| 2024-03-31 | 7.79M shares 10-Q · filed 2025-05-01 | |||||
| 2023-12-31 | 6.80M shares 10-K · filed 2026-02-12 | |||||
| 2023-09-30 | 6.91M shares 10-Q · filed 2024-10-31 | 6.91M shares 10-Q · filed 2024-10-31 | ||||
| 2023-06-30 | 7.26M shares 10-Q · filed 2024-08-01 | 7.26M shares 10-Q · filed 2023-08-03 | ||||
| 2023-03-31 | 7.52M shares 10-Q · filed 2024-05-02 | |||||
| 2022-12-31 | 6.93M shares 10-K · filed 2025-02-13 | |||||
| 2022-09-30 | 7.18M shares 10-Q · filed 2023-11-02 | 7.18M shares 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | 6.68M shares 10-Q · filed 2023-08-03 | 6.68M shares 10-Q · filed 2023-08-03 | ||||
| 2022-03-31 | 6.57M shares 10-Q · filed 2023-05-04 | |||||
| 2021-12-31 | 5.84M shares 10-K · filed 2024-02-15 | |||||
| 2021-09-30 | 6.12M shares 10-Q · filed 2022-11-03 | 6.12M shares 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | 6.47M shares 10-Q · filed 2022-08-04 | 6.47M shares 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | 7.45M shares 10-Q · filed 2022-05-05 | |||||
| 2020-12-31 | 7.47M shares 10-K · filed 2023-02-23 | |||||
| 2020-09-30 | 7.59M shares 10-Q · filed 2021-11-03 | 7.59M shares 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | 8.13M shares 10-Q · filed 2021-07-29 | 7.90M shares 10-Q · filed 2020-07-30 | 7.90M shares 10-Q · filed 2020-07-30 | |||
| 2020-03-31 | 8.13M shares 10-Q · filed 2021-04-29 | |||||
| 2019-12-31 | 7.09M shares 10-K · filed 2022-02-24 | |||||
| 2019-09-30 | 6.93M shares 10-Q · filed 2020-11-05 | 6.93M shares 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | 7.11M shares 10-Q · filed 2020-07-30 | 7.11M shares 10-Q · filed 2020-07-30 | ||||
| 2019-03-31 | 7.20M shares 10-Q · filed 2020-04-30 | |||||
| 2018-12-31 | 6.15M shares 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | 6.11M shares 10-Q · filed 2019-10-31 | 6.11M shares 10-Q · filed 2019-10-31 | ||||
| 2018-06-30 | 6.17M shares 10-Q · filed 2019-08-01 | 6.17M shares 10-Q · filed 2019-08-01 | ||||
| 2018-03-31 | 6.52M shares 10-Q · filed 2019-05-02 | |||||
| 2017-12-31 | 5.73M shares 10-K · filed 2020-02-19 | |||||
| 2017-09-30 | 5.95M shares 10-Q · filed 2018-11-01 | 5.95M shares 10-Q · filed 2018-11-01 | ||||
| 2017-06-30 | 6.20M shares 10-Q · filed 2018-08-02 | 6.20M shares 10-Q · filed 2018-08-02 | ||||
| 2017-03-31 | 6.26M shares 10-Q · filed 2018-05-04 | |||||
| 2016-12-31 | 5.32M shares 10-K · filed 2019-02-14 | |||||
| 2016-09-30 | 5.50M shares 10-Q · filed 2017-11-01 | 5.50M shares 10-Q · filed 2017-11-01 | 4.67M shares 10-Q · filed 2016-11-03 | |||
| 2016-06-30 | 5.47M shares 10-Q · filed 2017-08-08 | 5.47M shares 10-Q · filed 2017-08-08 | ||||
| 2016-03-31 | 5.40M shares 10-Q · filed 2017-05-04 | |||||
| 2015-12-31 | 4.64M shares 10-K · filed 2018-02-14 | |||||
| 2015-09-30 | 5.50M shares 10-Q · filed 2016-11-03 | 4.67M shares 10-Q · filed 2015-11-06 | 4.67M shares 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | 4.72M shares 10-Q · filed 2016-08-08 | 4.72M shares 10-Q · filed 2016-08-08 | ||||
| 2015-03-31 | 4.56M shares 10-Q · filed 2016-05-09 | |||||
| 2014-12-31 | 3.82M shares 10-K · filed 2017-02-16 | |||||
| 2014-09-30 | 1.48M shares 10-Q · filed 2015-11-06 | 3.83M shares 10-Q · filed 2015-11-06 | ||||
| 2014-06-30 | 4.00M shares 10-Q · filed 2015-08-07 | |||||
| 2014-03-31 | 3.98M shares 10-Q · filed 2015-05-11 | |||||
| 2013-12-31 | 3.87M shares 10-K · filed 2016-02-26 | |||||
| 2013-09-30 | 3.94M shares 10-Q · filed 2014-11-07 | 3.94M shares 10-Q · filed 2014-11-07 | ||||
| 2013-06-30 | 23.45M shares 10-Q · filed 2013-09-05 | 23.45M shares 10-Q · filed 2014-08-07 | ||||
| 2013-03-31 | 22.93M shares 10-Q · filed 2014-05-09 | |||||
| 2012-12-31 | 23.04M shares 10-K · filed 2015-02-24 | |||||
| 2012-09-30 | 23.14M shares 10-Q · filed 2013-11-07 | 23.14M shares 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | 23.22M shares 10-Q · filed 2013-09-05 | 23.22M shares 10-Q · filed 2013-09-05 | ||||
| 2011-12-31 | 22.72M shares 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |